Literature DB >> 28305085

Analysis of morphogenetic mutants of hydra : I. TheAberrant.

H C Schaller1, T Schmidt1, K Flick1, C J P Grimmelikhuijzen1.   

Abstract

A mutant ofHydra attenuata is analysed, theaberrant, which is distinct from the wild type in having a smaller head with fewer tentacles and only half the number of head-specific cells. The rate of head and foot regeneration and the doubling time are slower inaberrants than in normal hydra.The lower head-forming potential is paralleled by a reduced concentration of head-specific morphogens: compared to the wild type, in theaberrant the concentration of head activator is reduced to 70% in the head and to 50% in the body, the concentration of head inhibitor is reduced to 50% in the head and to 80% in the body. Theaberrant is more sensitive (3 times) to added head activator and less sensitive (>5 times) to added head inhibitor than the wild type.The slower rate of foot regeneration is paralleled by a lower content of foot-specific morphogens: compared to the wild type, in theaberrant the foot activator is reduced to 40% and the foot inhibitor to 70%.

Keywords:  Head formation; Hydra mutant; Morphogenetic substances

Year:  1977        PMID: 28305085     DOI: 10.1007/BF00867320

Source DB:  PubMed          Journal:  Wilehm Roux Arch Dev Biol        ISSN: 0340-0794


  9 in total

1.  Action of the head activator as a growth hormone in hydra.

Authors:  H C Schaller
Journal:  Cell Differ       Date:  1976-04

2.  Evidence for a foot-inhibiting substance in hydra.

Authors:  T Schmidt; H C Schaller
Journal:  Cell Differ       Date:  1976-10

3.  Bud formation inHydra: Inhibition by an endogenous morphogen.

Authors:  Stefan Berking
Journal:  Wilehm Roux Arch Dev Biol       Date:  1977-09

4.  Head regeneration inHydra is initiated release of head activator and inhibitor.

Authors:  H Chica Schaller
Journal:  Wilehm Roux Arch Dev Biol       Date:  1976-12

5.  A quantitative method for maceration of hydra tissue.

Authors:  Charles N David
Journal:  Wilhelm Roux Arch Entwickl Mech Org       Date:  1973-12

6.  Quantitative analysis of cell types during growth and morphogenesis in Hydra.

Authors:  H Bode; S Berking; C N David; A Gierer; H Schaller; E Trenkner
Journal:  Wilhelm Roux Arch Entwickl Mech Org       Date:  1973-12

7.  Regeneration of hydra from reaggregated cells.

Authors:  A Gierer; S Berking; H Bode; C N David; K Flick; G Hansmann; H Schaller; E Trenkner
Journal:  Nat New Biol       Date:  1972-09-27

8.  Isolation and characterization of a low-molecular-weight substance activating head and bud formation in hydra.

Authors:  H C Schaller
Journal:  J Embryol Exp Morphol       Date:  1973-02

9.  Mass culture of hydra: an improved method and its application to other aquatic invertebrates.

Authors:  H M Lenhoff; R D Brown
Journal:  Lab Anim       Date:  1970-04       Impact factor: 2.471

  9 in total
  6 in total

1.  Analysis of morphogenetic mutants of hydra : III.Maxi andMini.

Authors:  H C Schaller; T Schmidt; K Flick; C J P Grimmelikhuijzen
Journal:  Wilehm Roux Arch Dev Biol       Date:  1977-09

2.  Analysis of morphogenetic mutants of hydra : IV.Reg-16, a mutant deficient in head regeneration.

Authors:  Wolfgang Kemmner; H Chica Schaller
Journal:  Wilehm Roux Arch Dev Biol       Date:  1981-07

3.  Separation and specificity of action of four morphogens from hydra.

Authors:  H Chica Schaller; Tobias Schmidt; Cok J P Grimmelikhuijzen
Journal:  Wilehm Roux Arch Dev Biol       Date:  1979-06

4.  The fractionation of aHydra-derived inhibitor into head and foot inhibitors may be an artefact.

Authors:  Stefan Berking
Journal:  Wilehm Roux Arch Dev Biol       Date:  1983-11

5.  The head and the foot inhibitor from hydra are not dowex artefacts.

Authors:  H Chica Schaller
Journal:  Wilehm Roux Arch Dev Biol       Date:  1984-03

6.  Analysis of morphogenetic mutants of hydra : II. The non-budding mutant.

Authors:  H C Schaller; T Schmidt; K Flick; C J P Grimmelikhuijzen
Journal:  Wilehm Roux Arch Dev Biol       Date:  1977-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.